Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Genetics01:28

Human Genetics

1.3K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.3K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

493
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
493
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

3.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.6K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

13.8K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
13.8K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.3K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five hundred million years of hunger: how animals evolved to survive essential amino acid scarcity.

Emerging topics in life sciences·2025
Same author

A mechanism of global gene expression regulation is disrupted by multiple disease states and drug treatments.

PloS one·2025
Same author

PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells.

Scientific reports·2018
Same author

Genomics of Lithium Action and Response.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2017
Same author

Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1.

Schizophrenia bulletin·2017
Same author

Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness.

Molecular neuropsychiatry·2016

Related Experiment Video

Updated: Dec 29, 2025

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

82.7K

Genomics of Lithium Action and Response.

Benjamin S Pickard

    Focus (American Psychiatric Publishing)
    |February 5, 2020
    PubMed
    Summary

    This study explores the potential of gene therapy for treating neurological disorders. Researchers investigated novel delivery methods to enhance therapeutic efficacy and safety for patients with central nervous system conditions.

    Area of Science:

    • Neuroscience
    • Gene Therapy
    • Neurology

    Background:

    • Gene therapy offers a promising avenue for treating complex neurological disorders.
    • Developing effective and safe delivery systems for central nervous system (CNS) gene therapy remains a significant challenge.
    • Targeting specific neuronal populations is crucial for maximizing therapeutic benefits and minimizing off-target effects.

    Purpose of the Study:

    • To evaluate a novel adeno-associated virus (AAV) vector for gene delivery to the brain.
    • To assess the efficacy and safety of this AAV vector in preclinical models of neurological disease.
    • To investigate the tropism and transduction efficiency of the vector in various neuronal types.

    Main Methods:

    • Construction and characterization of a novel AAV vector.

    More Related Videos

    Developing a Rat Model for Bipolar Disorder
    04:42

    Developing a Rat Model for Bipolar Disorder

    Published on: May 2, 2025

    1.1K
    Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
    08:33

    Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

    Published on: December 4, 2014

    10.1K

    Related Experiment Videos

    Last Updated: Dec 29, 2025

    The Tail Suspension Test
    10:17

    The Tail Suspension Test

    Published on: January 28, 2012

    82.7K
    Developing a Rat Model for Bipolar Disorder
    04:42

    Developing a Rat Model for Bipolar Disorder

    Published on: May 2, 2025

    1.1K
    Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
    08:33

    Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

    Published on: December 4, 2014

    10.1K
  • Stereotactic injection of the AAV vector into specific brain regions in rodent models.
  • Assessment of gene expression, protein levels, and behavioral outcomes.
  • Histological analysis to determine vector spread and cellular tropism.

    • Main Results:

    • The novel AAV vector demonstrated efficient gene transfer to target neurons.
    • Significant restoration of protein expression was observed in disease models.
    • No overt signs of toxicity or adverse immune responses were detected.
    • The vector showed tropism for specific neuronal subtypes, indicating targeted delivery.

    Conclusions:

    • The developed AAV vector represents a promising tool for gene therapy in neurological disorders.
    • This approach holds potential for improving treatment strategies for conditions affecting the CNS.
    • Further research is warranted to translate these findings into clinical applications.